DarioHealth Reports Third Quarter 2024 Financial and Operating Results
Portfolio Pulse from
DarioHealth reported strong Q3 2024 financial results with a revenue of $7.42 million, marking an 18.7% increase over Q2 2024 and a 111% increase compared to Q3 2023. The growth was driven by the expansion of B2B2C revenues.
November 07, 2024 | 11:45 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
DarioHealth's Q3 2024 revenue increased by 18.7% from Q2 2024 and 111% from Q3 2023, driven by B2B2C revenue expansion.
The significant increase in revenue, both sequentially and year-over-year, indicates strong business momentum and successful expansion in the B2B2C segment, likely boosting investor confidence and positively impacting the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100